Patents Assigned to INOSITEC AG
  • CALCIUM OXALATE CRYSTALLIZATION INHIBITORS FOR RENAL DISORDERS
    Publication number: 20210347793
    Abstract: The present invention relates to inositol derivatives comprising two or more cyclohexanolpentakisester moieties linked by a common central linker and their use in therapy or prevention of a condition related to pathological crystallization. The invention further relates to useful intermediates in the synthesis of the compound of the invention.
    Type: Application
    Filed: September 18, 2019
    Publication date: November 11, 2021
    Applicant: INOSITEC AG
    Inventors: Mattias Emanuel IVARSSON, Jean-Christophe LEROUX, Anna KLETZMAYR
  • INOSITOL DERIVATIVES FOR USE IN PATHOLOGICAL CRYSTALLIZATION
    Publication number: 20210290643
    Abstract: The invention is related to an inositol polyphosphate oligo alkyl ether compound, or its pharmaceutically acceptable salt, for use in treatment or prevention of a disease associated with formation of calcium salt crystals.
    Type: Application
    Filed: June 7, 2021
    Publication date: September 23, 2021
    Applicants: ETH Zurich, INOSITEC AG
    Inventors: Anna Kletzmayr, Makoto Kuro-o, Hirosaka Hayashi, Mattias E. Ivarsson, Jean-Christophe Leroux